Lipoprotein(a) and Risk of Myocardial Infarction and Death in Chronic Kidney Disease | Zendy

Archna Bajaj | Zendy; Scott M. Damrauer | Zendy; Amanda H. Anderson | Zendy; Dawei Xie | Zendy; Matthew J. Budoff | Zendy; Alan S. Go | Zendy; Jiang He | Zendy; James P. Lash | Zendy; Akinlolu Ojo | Zendy; Wendy S. Post | Zendy; Mahboob Rahman | Zendy; Muredach P. Reilly | Zendy; Danish Saleheen | Zendy; Raymond R. Townsend | Zendy; Jinbo Chen | Zendy; Daniel J. Rader | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lipoprotein(a) and Risk of Myocardial Infarction and Death in Chronic Kidney Disease

Author(s) -

Archna Bajaj,

Scott M. Damrauer,

Amanda H. Anderson,

Dawei Xie,

Matthew J. Budoff,

Alan S. Go,

Jiang He,

James P. Lash,

Akinlolu Ojo,

Wendy S. Post,

Mahboob Rahman,

Muredach P. Reilly,

Danish Saleheen,

Raymond R. Townsend,

Jinbo Chen,

Daniel J. Rader

Publication year - 2017

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.117.309920

Subject(s) - medicine , hazard ratio , myocardial infarction , kidney disease , quartile , lipoprotein(a) , confidence interval , proportional hazards model , renal function , prospective cohort study , cardiology , risk factor , confounding , lipoprotein , cholesterol

To investigate the effect of LPA gene variants and renal function on lipoprotein(a) [Lp(a)] levels in people with chronic kidney disease and determine the association between elevated Lp(a) and myocardial infarction and death in this setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research